Brief Overview on Company’s Performance: Zimmer Biomet Holdings (NYSE: ZBH)


On Friday, Shares of Zimmer Biomet Holdings (NYSE: ZBH) lost -0.43% to $115.92. The stock grabbed the investor’s attention and traded 1,250,400 shares as compared to its average daily volume of 1.21M shares. The stock’s institutional ownership stands at 91.90%.

Zimmer Biomet Holdings Inc. (ZBH) stated a fourth-quarter loss of $901.10M, after reporting a profit in the same period a year earlier. On a per-share basis, the Warsaw, Indiana-based company said it had a loss of $4.42. Earnings, adjusted for asset impairment costs and non-recurring costs, were $2.18 per share. The results met Wall Street expectations. The average estimate of 14 analysts surveyed by Zacks Investment Research was also for earnings of $2.18 per share.

The orthopedic device maker posted revenue of $2.070B in the period, beating Street forecasts. Twelve analysts surveyed by Zacks expected $2.060B.

investment fraud lawyersRecover Your Investment Losses. Please Contact Haselkorn & Thibaut at 1 888-628-5590 or visit for a free consultation on recovering your investment losses.

For the year, the company stated a loss of $379.20M, or $1.86 per share, swinging to a loss in the period. Revenue was stated as $7.930B. It anticipates full-year earnings in the range of $7.70 to $7.90 per share.

ZBH has a market value of $24.08B while its EPS was booked as $-1.49 in the last 12 months. The stock has 207.72M shares outstanding. In the profitability analysis, the company has gross profit margin of 72.10% while net profit margin was -3.90%. Beta value of the company was 1.20; beta is used to measure riskiness of the security. Analyst recommendation for this stock stands at 2.30.

Scroll to Top